ELAPRASE 2mg (Idursulfase Vials) 2mg/ml x 5ml

Elaprase 2mg (idursulfase) is an enzyme replacement therapy for Hunter syndrome, a rare genetic disorder. Administered via intravenous infusion to manage symptoms associated with mucopolysaccharidosis II (MPS II). Suitable for patients diagnosed with this condition.

Strength

2mg/ml x 5ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Shire US Manufacturing Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Elaprase 2mg is used to treat Hunter syndrome, also known as mucopolysaccharidosis type II (MPS II). This condition is a rare genetic disorder caused by the lack of an enzyme called iduronate-2-sulfatase. The medication helps manage symptoms such as joint stiffness, respiratory issues, and organ enlargement by replacing the missing enzyme.

Side Effects

Elaprase 2mg works by providing the missing enzyme to break down complex sugars in the body. This can help reduce the buildup of these sugars in tissues and organs, potentially improving mobility and respiratory function. Patients may experience improved endurance and reduced discomfort over time.

Precautions & Warnings

Elaprase 2mg should be administered under the supervision of a healthcare professional experienced in enzyme replacement therapy. Patients may experience infusion-related reactions, so monitoring is essential. Keep the vials at room temperature and protect them from light until ready for use.

Avoid Interactions

No specific drug interactions have been established for Elaprase 2mg. However, caution is advised when combining with other medications that may affect the immune system. Always inform your healthcare provider about all medications and supplements you are taking before starting treatment.

Frequently Asked Questions

Elaprase 2mg is used to treat Hunter syndrome (MPS II), a rare genetic disorder caused by enzyme deficiency.

It is given as an intravenous infusion by a healthcare professional, typically every week.

Common effects may include headache, fever, or infusion-related reactions like chills or rash.

Yes, the vials should be kept at room temperature and protected from light until use.

Yes, this medication is prescription-only and should be administered under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.